World Journal of Laparoscopic Surgery

Register      Login

VOLUME 15 , ISSUE 1 ( January-April, 2022 ) > List of Articles

Original Article

Short-term Outcomes after Bariatric Surgery during the COVID-19 Pandemic

Koel Dutt, Claire Paice, Ciara Caleshu, Arun Ariyarathenam, ML Humphreys, David SY Chan

Keywords : Bariatric surgery, COVID-19 pandemic, Precautions, Roux-en-Y gastric bypass, Sleeve gastrectomy

Citation Information : Dutt K, Paice C, Caleshu C, Ariyarathenam A, Humphreys M, Chan DS. Short-term Outcomes after Bariatric Surgery during the COVID-19 Pandemic. World J Lap Surg 2022; 15 (1):26-30.

DOI: 10.5005/jp-journals-10033-1487

License: CC BY-NC 4.0

Published Online: 09-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background: Elective surgery, especially bariatric surgery, was stopped during the coronavirus disease-2019 (COVID-19) pandemic in the United Kingdom. Obesity is a major risk factor for COVID-19-related mortality. As the COVID-19 infection and mortality rates in Devon had been relatively low, bariatric procedures resumed with the necessary precautions in Plymouth with the easing of lockdown restrictions in mid-May. The aim of this study was to examine the outcome of bariatric surgery during the COVID-19 pandemic. Methods: Details of 38 patients, who underwent bariatric surgery between June 2020 and November 2020, were analyzed prospectively. All patients underwent a COVID-19 swab test 24–48 hours prior to the surgery. The primary outcome measure was COVID-19-related morbidity. Secondary outcomes were non-COVID-19-related morbidity, mortality, and weight loss at 6-week follow-up. Results: Thirty-eight patients [24 females; median age 51 (24–63) years, median body mass indices (BMI) at surgery 42.9 (32.4–62.5) kg/m2] underwent bariatric surgery. Thirty-seven patients were of White British ethnicity. No patient tested positive for COVID-19 pre- and postoperatively. No patient had any COVID-19-related morbidity or mortality. One patient developed a staple line bleed and returned to theater for relook laparoscopy and hemostasis. One patient developed an anastomotic leak and had a relook laparotomy for lavage and drain placement. The median length of hospital stay was 1 day. One patient was preplanned for intensive care admission and he stayed in a high dependency unit (HDU) for 1 day. All patients were followed up for 6 weeks and the median (range) excess weight loss (%EWL), at 6 weeks, was 24.4% (−0.9–53.6). Conclusion: Bariatric surgery can be performed safely in an area of low COVID-19 prevalence with the necessary precautions.


PDF Share
  1. WHO characterizes COVID-19 as a pandemic. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!.
  2. Yang W, Wang C, Shikora S, et al. Recommendations for metabolic and bariatric surgery during the COVID-19 pandemic from IFSO. Obes Surg 2020;30(6):2071–2073. DOI: 10.1007/s11695-020-04578-1.
  3. COVID-19 guidelines for triage of metabolic and bariatric surgery patients. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case/metabolic-bariatric [Accessed August 1, 2020].
  4. Nepogodiev D, Glasbey JC, Li E, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020;396(10243):27–38. DOI: 10.1016/S0140-6736(20)31182-X.
  5. BBC. Coronavirus UK map: How many confirmed cases are there in your area? 2020. Available from: https://www.bbc.co.uk/news/uk-51768274.
  6. Office of National Statistics. Deaths involving COVID-19. 2020. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19bylocalareasanddeprivation/deathsoccurringbetween1marchand31may2020.
  7. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61(4):344–349. DOI: 10.1016/j.jclinepi.2007.11.008.
  8. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg 2004;240(2):205–213. DOI: 10.1097/01.sla.0000133083.54934.ae.
  9. BOMSS guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery. 2014. Available from: BOMSS.org.uk.
  10. Francis N, Dort J, Cho E, et al. SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic. Surg Endosc 2020;34(6):2327–2331. DOI: 10.1007/s00464-020-07565-w.
  11. Syed AA, Soran H, Adam S. Obesity and covid-19: the unseen risks. British Medical Association 2020;370:m2823. DOI: 10.1136/bmj.m2823.
  12. Lim S, Shin SM, Nam GE, et al. Proper management of people with obesity during the COVID-19 pandemic. J Obes Metab Syndr 2020;29(2):84–98. DOI: 10.7570/jomes20056.
  13. Fruh SM, Nadglowski J, Hall HR, et al. Obesity stigma and bias. J Nurse Pract 2016;12(7):425–432. DOI: 10.1016/j.nurpra.2016.05.013.
  14. Rubino F, Shukla A, Pomp A, et al. Bariatric, metabolic, and diabetes surgery: what's in a name? Ann Surg 2014;259(1):117–122. DOI: 10.1097/SLA.0b013e3182759656.
  15. Excess weight and COVID-19 insights from new evidence. Public Health England. 2020. Available from: https://www.gov.uk/government/publications/excess-weight-and-covid-19-insights-from-new-evidence.
  16. Scheen AJ. Obésité et risque de COVID-19 sévère [Obesity and risk of severe COVID-19]. Rev Med Suisse 2020;16(695):1115–1119. PMID: 32462841.
  17. Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis 2020;71(15):896–897. DOI: 10.1093/cid/ciaa415.
  18. Rubino F, Cohen RV, Mingrone G, et al. Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diab Endocrinol 2020;8(7):640–648. DOI: 10.1016/S2213-8587(20)30157-1.
  19. Navarra G, Komaei I, Currò G, et al. Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown. Updates Surg 2020;72(2):259–268. DOI: 10.1007/s13304-020-00821-7.
  20. Executive Council of ASMBS. Safer through surgery: American Society for Metabolic and Bariatric Surgery statement regarding metabolic and bariatric surgery during the COVID-19 pandemic. Surg Obes Relat Dis 2020;16(8):981–982. DOI: 10.1016/j.soard.2020.06.003.
  21. Kim J, Eisenberg D, Azagury D, et al. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis 2016;12(3):453–459. DOI: 10.1016/j.soard.2015.11.021.
  22. Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res 2016;118(11):1844–1855. DOI: 10.1161/CIRCRESAHA.116.307591.
  23. Prachand VN, Milner R, Angelos P, et al. Medically necessary, time-sensitive procedures: scoring system to ethically and efficiently manage resource scarcity and provider risk during the COVID-19 pandemic. J Am Coll Surg 2020;231(2):281–288. DOI: 10.1016/j.jamcollsurg.2020.04.01.
  24. Chan D, MacCormick A, Rashid B, et al. Short-term outcomes after Ivor-Lewis oesophagectomy for cancer during the COVID-19 pandemic. Ann R Coll Surg Engl 2021;103(2):134–137.
  25. Kassir R, Debs T, Blanc P, et al. Complications of bariatric surgery: presentation and emergency management. Int J Surg 2016;27:77–81. DOI: 10.1016/j.ijsu.2016.01.067.
  26. Schulman AR, Thompson CC. Complications of bariatric surgery: what you can expect to see in your GI practice. Am J Gastroenterol 2017;112(11):1640–1655. DOI: 10.1038/ajg.2017.241.
  27. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014;149(3):275–287. DOI: 10.1001/jamasurg.2013.3654.
  28. UK Health Security Agency. The R number and growth rate in the UK [Internet]. [cited 2020 Jun 21]. Available from: https://www.gov.uk/guidance/the-r-number-in-the-uk.
  29. Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty 2020;35(7S):S74–S81. DOI: 10.1016/j.arth.2020.04.055.
  30. Abbasi J. The promise and peril of antibody testing for COVID-19. Journal of the American Medical Association 2020;323(19):1881–1883. DOI: 10.1001/jama.2020.6170.
  31. Tang YW, Schmitz JE, Persing DH, et al. Laboratory diagnosis of COVID-19: current issues and challenges. J Clin Microbiol 2020;58(6):e00512–e00520. DOI: 10.1128/JCM.00512-20.
  32. West CP, Montori VM, Sampathkumar P. COVID-19 testing: the threat of false-negative results. Mayo Clin Proc 2020;95(6):1127–1129. DOI: 10.1016/j.mayocp.2020.04.004.
  33. England Royal College of Surgeons of England of surgical services during and after COVID-19. 2020. Available from: https://www.rcseng.ac.uk/coronavirus/recovery-of-surgical-services/#s1.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.